No long-term psychological morbidity living with an implantable cardioverter defibrillator under advisory: The Medtronic Marquis experience

Europace

Volumn 11, Issue 1, 2009, Pages 26-30

  Birnie, David H ^a   Sears, Samuel F ^b   Green, Martin S ^a   Lemery, Robert ^a   Gollob, Michael H ^a   Amyotte, Barbara ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Advisory; Anxiety; ICD; Psychological morbidity; Recall

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE SEVERITY; FEMALE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT ATTITUDE; PRIORITY JOURNAL; SCORING SYSTEM; STRUCTURED QUESTIONNAIRE;

AGED; ANXIETY; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MIDDLE AGED; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS;

EID: 58149096524     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun317     Document Type: Article

References (20)

1. Sears SF Jr, Conti JB. Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators. Am J Cardiol 2006;98:565-7.
2. van den Broek KC, Denollet J, Nyklicek I, Van der Voort PH. Psychological reaction to potential malfunctioning of implantable defibrillators. Pacing Clin Electrophysiol 2006;29:953-6.
3. Cuculi F, Herzig W, Kobza R, Erne P. Psychological distress in patients with ICD recall. Pacing Clin Electrophysiol 2006;29:1261-5.
4. Gibson DP, Kuntz KK, Levenson JL, Ellenbogen KA. Decision-making, emotional distress, and quality of life in patients affected by the recall of their implantable cardioverter defibrillator. Europace 2008;10:540-4.
5. Medtronic Inc. Medtronic Marquis Patient Management Information. Medtronic Inc., Minnesota, USA; 2005.
6. Burns JL, Serber ER, Keim S, Sears SF. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol 2005;16:384-90.
7. Pedersen SS, Spindler H, Johansen JB, Mortensen PT, Sears S. Correlates of patient acceptance of the cardioverter-defibrillator: cross-validation of the Florida Patient Acceptance Survey in Danish patients. Pacing Clin Electrophysiol 2008;31:1168-77.
8. Israel CW, Barold SS. Electrical storm in patients with an implanted defibrillator: a matter of definition. Ann Noninvasive Electrocardiol 2007;12:375-82.
9. Sears SF Jr, Todaro JF, Lewis TS, Sotile W, Conti JB. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol 1999;22:481-9.
10. Sears SF, Lewis TS, Kuhl EA, Conti JB. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics 2005;46:451-7.
11. Groeneveld PW, Matta MA, Suh JJ, Yang F, Shea JA. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era. Pacing Clin Electrophysiol 2007;30:463-71.
12. Duru F, Buchi S, Klaghofer R, Mattmann H, Sensky T, Buddeberg C et al. How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life? Heart 2001;85:375-9.
13. Leosdottir M, Sigurdsson E, Reimarsdottir G, Gottskalksson G, Torfason B, Vigfusdottir M et al. Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients. Europace 2006;8:168-74.
14. Maisel WH. Pacemaker and ICD generator reliability: meta-analysis of device registries. JAMA 2006;295:1929-34.
15. Whang W, Albert CM, Sears SF Jr, Lampert R, Conti JB, Wang PJ et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 2005;4:1090-5.
16. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002;105:589-94.
17. Pedersen SS, Theuns DA, Muskens-Heemskerk A, Erdman RA, Jordaens L. Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation. Europace 2007;9:675-80.
18. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002;144:282-9.
19. Medtronic Inc. Urgent Medical Device Information: Sprint Fidelis Lead Recall and Patient Management Recommendations. Medtronic Inc., Minnesota, USA; 2007.
20. Hauser RG, Kallinen LM, Almquist AK, Gornick CC, Katsiyiannis WT. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm 2007;4:892-6.